Telesis Bio gains up to $21M to boost Gibson SOLA adoption

Date:

Telesis Bio has announced its entry into a convertible preferred stock purchase agreement, aiming to sell shares of a newly designated series of convertible preferred stock through a private placement. This transaction is expected to generate gross proceeds of approximately $21 million.

Source link

DMN8 Partners
DMN8 Partnershttps://salvonow.com/
DMN8 Partners utilizes a strategy of Cross Channel marketing including local search engine optimization, PPC, messaging and hyper-targeted audiences allow our clients to experience results and ROI that fuel growth and expansion in their operations. There are a lot of digital marketing options across the country but partnering with an agency that understands multiple touches on multiple platforms allows your company’s message to be seen at the perfect time, on the perfect platform, by your perfect prospect. DMN8 Partners has had years of experience growing businesses. Start growing your business today and begin DOMINATE-ing your market.

More like this
Related

Tech Sell-Off Accelerates, Driving Wall Street Stocks Lower

The White House Watch newsletter, offering insights into the...

Top 30+ Apple Deals Before Amazon’s Big Spring Sale

Bethany Allard is a shopping reporter based in Los...

Greek Bonds Steady Following Offering

Hellenic Republic bonds have maintained stability following a recent...

Keeping Cats and Backyard Chickens Safe from Bird Flu

For cats that enjoy outdoor activities, Feah suggests that...